Skip to main content

Table 1 Baseline participant demographic and assessment data (n = 36)

From: Consecutive sessions of transcranial direct current stimulation do not remediate visual hallucinations in Lewy body dementia: a randomised controlled trial

  Active (n = 19) Placebo (n = 17) p value
Mean SD Mean SD
Age (years) 76.31 8.79 73.88 6.97 0.369
Gender (male/female) 15 (78.9%)/4 (21.1%) 12 (70.6%)/5 (29.4%) 0.563
DLB/PDD 12 (63.2%)/7 (36.8%) 11 (64.7%)/6 (35.3%) 0.923
Levodopa equivalent dose (mg) 225.63 318.79 186.73 264.87 0.695
Cognitive fluctuations, n (%) 18 (94.7%) 17 (100%) 0.337
Parkinsonism, n (%) 14 (73.7%) 14 (82.4%) 0.532
REM behaviour disorder, n (%) 11 (52.4%)   12 (63.2%)   0.491
MMSE 18.16 6.56 17.88 6.06 0.897
CAMCOG (total) 60.05 22.91 58.24 21.39 0.808
NPI hallucinations subscale 4.42 2.80 4.47 3.16 0.961
CAF 6.32 3.92 5.65 2.55 0.553
ODFAS 4.58 3.39 4.71 2.97 0.906
UPDRS-III 36.83 25.07 32.36 21.93 0.561
TMT A (% completion) 52.2%   47.8%   0.923
TMT B (% completion) 5.3%   5.9%   0.935
FAS 17.26 14.75 14.94 11.21 0.602
GDS-15 6.81 4.31 6.27 2.91 0.681
IADL 3.12 2.52 2.47 2.26 0.451
CDR (total) 1.24 0.71 1.29 0.56 0.790
  1. SD standard deviation, DLB dementia with Lewy bodies, PDD Parkinson’s disease dementia, REM rapid eye movement, MMSE Mini-Mental State Examination, CAMCOG Cambridge Cognitive Examination, NPI Neuropsychiatric Inventory, CAF Cognitive Assessment of Fluctuation, ODFAS One Day Fluctuation Scale, UPDRS-III Unified Parkinson’s Disease Rating Scale, TMT Trail Making Test, GDS-15 Geriatric Depression Scale (15-item version), IADL Individual Activities of Daily Living; CDR Clinical Dementia Rating
\